The expression of c-Met has been abnormally increased in HCC patients (18, 19), and suppression of c-Met can inhibit cell proliferation, invasion and epithelial-mesenchymal transition and other biological processes of tumor (20, 21). This evidence concerns the gene MET and hepatocellular carcinoma.